{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1010000782048427278.json","@type":"Article","resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"ja","@value":"Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin."}],"publication":{"prism:publicationName":[{"@language":"ja","@value":"J Viral Hepat 16(8)"}],"prism:publicationDate":"2009","prism:startingPage":"586","prism:endingPage":"94"},"reviewed":"true","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782048427264","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"20590777"},{"@type":"JGN","@value":"JP20590777"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20590777/"}],"notation":[{"@language":"ja","@value":"糖鎖技術を用いた新しいNASHの病態解析"},{"@language":"en","@value":"Analysis of NASH pathophysiology using glycobiological technique"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"PRODUCT-12298074"}]}